{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:56:26Z","timestamp":1789016186250,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaip.2017.04.042","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T10:15:32Z","timestamp":1498731332000},"page":"260-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Detection of anti\u2013glutamic acid decarboxylase antibodies in immunoglobulin products"],"prefix":"10.1016","volume":"6","author":[{"given":"Tukisa D.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.04.042_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2013.845527","article-title":"Immunology of stiff person syndrome and other GAD-associated neurological disorders","volume":"9","author":"Alexopoulos","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.042_bib2","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1212\/WNL.55.10.1531","article-title":"The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome","volume":"55","author":"Dalakas","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jaip.2017.04.042_bib3","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the American Academy of Allergy, Asthma and Immunology (AAAAI)","volume":"117","author":"Orange","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.042_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.04.042_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/ped.2010.0009","article-title":"In\u00a0vivo assessment of clinically relevant autoantibodies in intravenous immunoglobulin preparations","volume":"23","author":"Abbott","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/j.jaip.2017.04.042_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/jcp.52.3.177","article-title":"Atypical c-ANCA following high dose intravenous immunoglobulin","volume":"52","author":"Jolles","year":"1999","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jaip.2017.04.042_bib7","first-page":"872","article-title":"Intravenous immunoglobulin contains detectable amounts of antiphospholipid antibodies","volume":"96","author":"Stratta","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2017.04.042_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1139::AID-IMMU1139>3.0.CO;2-J","article-title":"Human anti-Fc epsilon RI alpha autoantibodies isolated from healthy donors","volume":"29","author":"Horn","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaip.2017.04.042_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-3148.1999.00214.x","article-title":"Epitope-specific glutamic acid decarboxylase-65 autoantibodies in intravenous immunoglobulin preparations","volume":"9","author":"Hao","year":"1999","journal-title":"Transfus Med"},{"key":"10.1016\/j.jaip.2017.04.042_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.clineuro.2009.03.010","article-title":"False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin","volume":"111","author":"de Beer","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jaip.2017.04.042_bib11","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/archneurol.2011.991","article-title":"Stiff-man syndrome and variants: clinical course, treatments, and outcomes","volume":"69","author":"McKeon","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaip.2017.04.042_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1084\/jem.180.2.595","article-title":"Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus","volume":"180","author":"Kim","year":"1994","journal-title":"J\u00a0Exp Med"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817303586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:51Z","timestamp":1761974031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817303586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213219817303586"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.042","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of anti\u2013glutamic acid decarboxylase antibodies in immunoglobulin products","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}